November 3, 2025 - 05:28

Dürr, a prominent player in plant engineering and automation, has successfully finalized the sale of its environmental technology division, known as Clean Technology Systems, to Stellex. This strategic move is part of Dürr’s broader initiative to streamline its operations and focus on its core business areas, particularly in robotics and automation.
The environmental technology business has been a crucial part of Dürr's portfolio, specializing in innovative solutions aimed at reducing emissions and enhancing sustainability. By transferring ownership to Stellex, Dürr aims to ensure that the division can continue to thrive and expand under new management, which is expected to bring fresh perspectives and resources to the table.
This transaction aligns with the growing trend of companies prioritizing sustainability and environmental responsibility in their operations. As the demand for eco-friendly technologies continues to rise, the sale is anticipated to benefit both Dürr and Stellex, allowing them to concentrate on their respective strengths while contributing to a greener future.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...